Nonalcoholic Fatty Liver Disease (NAFLD) Pharmacological Treatment: Metformin Versus Atorvastatin
Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The first line approach to NAFLD is currently based on diet and lifestyle modification. Aim
of our Unit is to compare the efficacy of two different doses of metformin (1 g/day and 2
g/day) with atorvastatin (20 mg/day) on amelioration of inflammatory and cardiometabolic
parameters, ultrasound signs and clinical scores associated with liver fibrosis in
early-stage NAFLD non-diabetic patients.